Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Caris Life Sciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get CAI alerts

About David Spetzler

The proxy statement of Caris Life Sciences, Inc. reports total compensation of $11,583,227 for David Spetzler in fiscal 2025, including a base salary of $611,934. Disclosed compensation is on record for 2 fiscal years. David Spetzler has spoken on 5 earnings calls across 1 company, most recently for Caris Life Sciences, Inc. on November 4, 2026. Caris Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Caris Life Sciences, Inc. includes David Dean Halbert (CEO), Jeffrey Vacirca (CEO), Brian J. Brille (Chairman) and 6 others.

David Spetzler on recent calls

“I will walk through the two new products and then the foundation model behind our digital AI platform, our planned expansion of our Achieve program for CARES Detect, and we'll close on interception.”
Other, Caris Third Quarter 2026 Financial Results Conference Call ·
“I will walk through some product updates along with the next phase of development because the numbers you just heard are downstream of it. Everything I'm about to walk through comes back to a single idea you heard from David at the open.”
Other, Caris Second Quarter 2026 Financial Results Conference Call ·
“Yes and one of the reasons why we also disclosed kind of that the exit rate on the completions for February and March is what also gives us confidence.”
Other, Caris Life Sciences, Inc. Q1 FY2026 Earnings Call ·
“So, getting to our Achieve One interim results that we wanted to share today and are reflected on slide eight. As you are aware, this study is for supporting the upcoming launch of Keras Detect, our whole genome sequencing-based MSED blood test in Q2 of 2026.”
Other, Caris Life Sciences, Inc. Q4 FY2025 Earnings Call ·
“We don't know how they'll necessarily respond and what additional data that they will want, but we do have additional data ready, and some of the studies that we listed will be reported out soon.”
Other, Caris Life Sciences, Inc. Q3 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Caris Life Sciences, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Caris Life Sciences, Inc. (CAI) $611,934 $11,583,227
2024 Caris Life Sciences, Inc. (CAI) $600,000 $1,213,800

Recent activity